Clinical Trial Interpretation
Cross-source consensus on Clinical Trial Interpretation from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Evidence quality
Highlighted claims
- Failure to meet a primary endpoint does not necessarily make a clinical trial scientifically uninformative. — Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas
- Trials in rare, aggressive, molecularly complex cancers can provide value beyond a single endpoint result. — Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas
- Clinical trials can test whether biomarker-based strategies are feasible. — Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas
- Clinical trials can reveal biological mechanisms of response or resistance. — Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas